Guess which ASX healthcare stock is rocketing on an 'unprecedented opportunity' with a global giant

This healthcare stock is working closely with a giant in its field.

| More on:
A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

4DMedical Ltd (ASX: 4DX) shares are catching the eye on Wednesday.

In morning trade, the ASX healthcare share was up as much as 20% to $1.10.

Its shares have since pulled back a touch but remain up 13% to $1.04.

Why is this ASX healthcare stock rocketing?

Investors have been scrambling to buy the company's shares this morning after it announced a memorandum of understanding with healthcare giant, Philips N.V. (NYSE: PHG).

According to the release, the two parties will look to establish a strategic collaboration to expand federal and commercial sales opportunities for XV Technology in North America.

4DMedical's flagship patented XV Technology enables physicians to understand regional airflow in the lungs and identify respiratory deficiencies earlier and with greater sensitivity as they breathe.

The ASX healthcare stock notes that the signing of this memorandum of understanding represents a major step forward in its commercialisation strategy, particularly within the U.S. Veterans Health Administration (VA).

This is because Philips has a long-established and significant existing partnership with both the VA and the Department of Defense (DoD). This includes a 45-year relationship, deploying 35% of the critical care information systems across the VA. It also has Philips imaging solutions in 50% of VA hospitals and Veterans Integrated Service Networks (VISNs).

Management believes that accessing this team of industry experts, with "unparalleled relationships" in global healthcare, provides an "unprecedented opportunity" to accelerate its go-to-market activities.

The ASX healthcare stock's founder and CEO, Andreas Fouras, said:

To partner with a healthcare powerhouse such as Philips is a phenomenal opportunity for 4D to accelerate our mission. The depth of commitment to Veterans by the team at Philips North America has been palpable throughout our 6-month long discussions. I continue to be impressed by their leadership in this space, and I am convinced that a partnership with Philips will dramatically accelerate the scaling of our offering within the VA. I am incredibly excited by the reach this will give our technology, and importantly, the impact this will have for millions of Veterans and their caregivers.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A couple sit in their home looking at a phone screen as if discussing a financial matter.
Share Market News

APA Group gains $1bn extra funding capacity after S&P credit rating change

S&P’s credit rating change gives APA Group over $1 billion in extra capacity to fund new energy infrastructure projects.

Read more »

two men in suits shake hands at the top of a shined wood boardroom table.
Share Market News

DigiCo Infrastructure REIT appoints new CEO and sets strategic growth path

DigiCo Infrastructure REIT has appointed Michael Juniper as CEO, with a focus on powering the next phase of digital infrastructure…

Read more »

Four smiling young medics with arms crossed stand outside a hospital.
Share Market News

Telix Pharmaceuticals updates investors as first patient is dosed in Phase 3 prostate cancer trial

Telix Pharmaceuticals updates on its prostate cancer Phase 3 trial, dosing the first Part 2 patient and outlining regulatory plans.

Read more »

Work meeting among a diverse group of colleagues.
Share Market News

National Storage REIT agrees to $4bn Brookfield-GIC buyout: What it means for investors

National Storage REIT has agreed to a $4bn all-cash acquisition by Brookfield and GIC, offering investors a significant premium.

Read more »

Man in shirt and tie falls face first down stairs.
Share Market News

Corporate Travel Management and Boss Energy shares dumped from ASX 200

Six shares will exit the ASX 200 later this month as part of the next S&P Dow Jones Indices rebalance.

Read more »

Three happy team mates holding the winners trophy.
Share Market News

BHP shares surge 8% on their way to reclaiming the No. 1 title from CBA

BHP may be on its way to reclaiming the ASX 200's No. 1 spot as CBA shares continue their steep…

Read more »

A man looking at his laptop and thinking.
Share Market News

5 things to watch on the ASX 200 on Monday

A soft start to the week is expected for Aussie investors.

Read more »

A man leaps from a stack of gold coins to the next, each one higher than the last.
Share Market News

6 ASX shares including Ora Banda and Aussie Broadband ascend into ASX 200

S&P Dow Jones Indices has just announced details of the December quarter rebalance.

Read more »